HPAI

Cal-Maine Foods, Inc. Reports Positive Test Result for Avian Influenza at Texas Facility

Retrieved on: 
Tuesday, April 2, 2024

Production at the facility has temporarily ceased as the Company follows the protocols prescribed by the USDA.

Key Points: 
  • Production at the facility has temporarily ceased as the Company follows the protocols prescribed by the USDA.
  • Cal-Maine Foods is working to secure production from other facilities to minimize disruption to its customers.
  • The Company remains dedicated to robust biosecurity programs across its locations; however, no farm is immune from HPAI.
  • The APHIS division of the USDA and individual states track and publicly report individual incidents of HPAI by location.

Cal-Maine Foods Reports Results for Third Quarter Fiscal 2024

Retrieved on: 
Tuesday, April 2, 2024

Cal-Maine Foods, Inc. (NASDAQ: CALM) (“Cal-Maine Foods” or the “Company”), the largest producer and distributor of fresh shell eggs in the United States, today reported results for the third quarter of fiscal 2024 (thirteen weeks) ended March 2, 2024.

Key Points: 
  • Cal-Maine Foods, Inc. (NASDAQ: CALM) (“Cal-Maine Foods” or the “Company”), the largest producer and distributor of fresh shell eggs in the United States, today reported results for the third quarter of fiscal 2024 (thirteen weeks) ended March 2, 2024.
  • “The net average selling price per dozen was $2.152 for conventional eggs in the third quarter of fiscal 2024, down 41.5% compared with $3.678 for the prior-year quarter.
  • For the third quarter of fiscal 2024, feed costs per dozen were down 19.9% compared with the third quarter of fiscal 2023.
  • Soybean meal supply has remained tight relative to demand in the third quarter of fiscal 2024.”

Avangrid Foundation Awards $140,000 to Wildlife Rehabilitation Centers

Retrieved on: 
Friday, February 23, 2024

The Avangrid Foundation, the primary philanthropic arm of leading sustainable energy company Avangrid, Inc. (NYSE: AGR), today announced a record total of $140,000 in grants to 15 wildlife rehabilitation centers as part of its Wildlife Rehabilitation Program.

Key Points: 
  • The Avangrid Foundation, the primary philanthropic arm of leading sustainable energy company Avangrid, Inc. (NYSE: AGR), today announced a record total of $140,000 in grants to 15 wildlife rehabilitation centers as part of its Wildlife Rehabilitation Program.
  • Now in its eighth year, Avangrid Foundation’s Wildlife Rehabilitation Program has given a total of more than $650,000 in grants to centers nationwide.
  • “We are very proud to help combat these risks through the Avangrid Foundation’s Wildlife Rehabilitation Program.
  • A big thank you to everyone at Avangrid and the Avangrid Foundation.”
    For more information on the Avangrid Foundation, click here .

Cal-Maine Foods, Inc. Reports Positive Test Result for Avian Influenza at Kansas Facility

Retrieved on: 
Tuesday, December 12, 2023

Production at the facility has temporarily ceased as the Company follows the protocols prescribed by the USDA.

Key Points: 
  • Production at the facility has temporarily ceased as the Company follows the protocols prescribed by the USDA.
  • According to the USDA, these detections do not present an immediate public health concern and are not a threat to the food supply.
  • Also, according to the USDA, HPAI cannot be transmitted through safely handled and properly cooked eggs or poultry.
  • There have been no positive tests for HPAI at any other Cal-Maine Foods locations to date.

Longhorn Vaccines and Diagnostics Announces Data Showing PrimeStore® Molecular Transport Medium Inactivates High Consequence Animal Viruses

Retrieved on: 
Thursday, October 12, 2023

Zoonotic diseases are a significant threat to human and animal populations and global food production.

Key Points: 
  • Zoonotic diseases are a significant threat to human and animal populations and global food production.
  • This includes the SARS-CoV-2 global pandemic that has dramatically affected humans and domestic and wild animal species.
  • The study, titled “Inactivation of Highly Transmissible Livestock and Avian Viruses Including Influenza A and Newcastle Disease Virus for Molecular Diagnostics,” found:
    PS-MTM completely inactivates viruses representing highly contagious animal diseases in the presence of species-relevant sample matrices.
  • Add to that the biosafety and biosecurity risks of transporting high consequence disease samples and the typical need to keep samples cold.

California Condor Recovery Program Implements Vaccines in Pre-Release Condors Based on Early Trial Results

Retrieved on: 
Monday, October 16, 2023

LOS ANGELES and SAN DIEGO, and PORTLAND, Ore., Oct. 16, 2023 /PRNewswire/ -- The U.S. Fish & Wildlife Service (Service) is sharing early results from the historic vaccine trial for highly pathogenic avian influenza (HPAI) in California condors (Gymnogyps californianus). As reported by the Service's Incident Command leading the effort, results from the first test group showed that 60% of the condors produced measurable antibodies that are expected to provide partial protection against mortality from HPAI if the birds are exposed.

Key Points: 
  • Fish & Wildlife Service (Service) is sharing early results from the historic vaccine trial for highly pathogenic avian influenza (HPAI) in California condors (Gymnogyps californianus).
  • Zoo), San Diego Zoo Wildlife Alliance (SDZWA), and the Oregon Zoo as longtime California Condor Recovery Program partners, and with a new recovery partner, the Carolina Raptor Center.
  • None of this important work would be possible without the collaboration from all our partners," said Ashleigh Blackford, California Condor Recovery Program Coordinator for the Service.
  • The California Condor Recovery Program has long been an example of how partnerships can help promote recovery of endangered species.

Cal-Maine Foods Reports Results for First Quarter Fiscal 2024

Retrieved on: 
Tuesday, October 3, 2023

Sherman Miller, president and chief executive officer of Cal-Maine Foods, Inc., stated, “Our results for the first quarter of fiscal 2024 reflect the current dynamic market conditions.

Key Points: 
  • Sherman Miller, president and chief executive officer of Cal-Maine Foods, Inc., stated, “Our results for the first quarter of fiscal 2024 reflect the current dynamic market conditions.
  • Net income for the first quarter of fiscal 2024 was $926,000, or $0.02 per diluted share, compared with $125.3 million, or $2.57 per diluted share, for the first quarter of fiscal 2023.
  • “Conventional egg net average selling price per dozen was $1.241 for the first quarter of fiscal 2024 compared with $2.368 for the prior-year quarter.
  • For the first quarter of fiscal 2024, feed costs per dozen were $0.597, a 10.5% decrease compared with the first quarter of fiscal 2023.

CSL Seqirus Announces Third U.S. Government Award in Relation to Influenza A(H5N8) Candidate Vaccine

Retrieved on: 
Monday, August 28, 2023

This acquisition of a bulk lot will increase BARDA's stockpile of vaccine to support rapid response in an associated influenza pandemic.

Key Points: 
  • This acquisition of a bulk lot will increase BARDA's stockpile of vaccine to support rapid response in an associated influenza pandemic.
  • Under the terms of the agreement, CSL Seqirus will deliver one bulk lot of H5N8 A/Astrakhan antigen to support the U.S. government's pandemic response readiness.
  • CSL Seqirus used its cell-based influenza vaccine technology, as utilized for FDA-approved AUDENZ™ (Influenza A(H5N1) Monovalent Vaccine, Adjuvanted), to manufacture the H5N8 A/Astrakhan bulk vaccine at the company's Holly Springs, North Carolina, facility, which was built in partnership with BARDA.
  • CSL Seqirus established and will maintain the required pandemic readiness to deliver 150 million doses of cell-based pandemic influenza vaccine within six months of an influenza pandemic declaration in the U.S.

Cal-Maine Foods Reports Results for Fourth Quarter and Fiscal Year 2023

Retrieved on: 
Tuesday, July 25, 2023

Cal-Maine Foods, Inc. (NASDAQ: CALM) (“Cal-Maine Foods” or the “Company”), the largest producer and distributor of fresh shell eggs in the United States, today reported results for the fourth quarter of fiscal 2023 (fourteen weeks) and fiscal year 2023 (fifty-three weeks) ended June 3, 2023.

Key Points: 
  • Cal-Maine Foods, Inc. (NASDAQ: CALM) (“Cal-Maine Foods” or the “Company”), the largest producer and distributor of fresh shell eggs in the United States, today reported results for the fourth quarter of fiscal 2023 (fourteen weeks) and fiscal year 2023 (fifty-three weeks) ended June 3, 2023.
  • “Conventional egg net average selling price per dozen was $2.038 for the fourth quarter of fiscal 2023 compared with $2.108 the prior-year quarter and $2.739 for fiscal 2023.
  • “We reported operating income of $136.2 million for the fourth quarter of fiscal 2023, compared with $145.7 million for the prior year quarter, and operating income of $967.7 million for fiscal 2023 compared with $143.5 million for fiscal 2022.
  • For the fourth quarter of fiscal 2023, feed costs per dozen were $0.671, a 4.7% increase compared with the fourth quarter of fiscal 2022.

Migrating birds could bring lethal avian flu to Australia's vulnerable birds

Retrieved on: 
Wednesday, May 3, 2023

In 2021, avian influenza evolved into a new form – a new and remarkably lethal variant first found in Europe.

Key Points: 
  • In 2021, avian influenza evolved into a new form – a new and remarkably lethal variant first found in Europe.
  • Bird flu is usually most dangerous to birds kept in close quarters, such as chicken farms.
  • But as it spread around the world, the highly pathogenic HPAI A(H5N1) variant began killing millions and millions of wild birds too.
  • Black swans, for instance, are especially vulnerable to all types of avian flu.

Could it really get here?

    • Instead, the government is likely to focus on the major wetlands and shallow inlets which attract migratory birds.
    • Responses like the mass destruction of beehives after the devastating varroa mite arrived are unlikely to work for a virus.
    • A tailored vaccine could help domestic birds, but it would be all but impossible to administer to wild birds.
    • Read more:
      Australia's iconic black swans have a worrying immune system deficiency, new genome study finds

Haven’t our birds survived bird flu before?

    • In 2020, three egg producers in Victoria had an outbreak of another highly pathogenic influenza variant, H7N7.
    • To stop it spreading, authorities culled all birds in the farms.
    • This variant emerged when low pathogenic viruses carried by local wild birds evolved into a deadlier form.
    • But if the virus gets into wild birds and takes off, we have no plan.

We must prepare

    • As we back nature into a corner, we can find ourselves more exposed to the viruses wild animals carry.
    • That’s a similar death rate to many of the birds dying of the avian flu elsewhere in the world.
    • The main protection we have at present is the fact avian flu finds it hard to infect us in the first place.